The renin-angiotensin system antagonism in the treatment of hypertension John D. BisognanoRobert J. Cody Invited Commentary Pages: 275 - 277
Surfing from scratch: An introduction to medical searches on the internet Naomi D. L. Fisher Web Alert Pages: 279 - 280
Mechanism of action of angiotensin-receptor blocking agents Helmy M. SiragyMartin Bedigian OriginalPaper Pages: 289 - 295
Old antihypertensive agents-diuretics and β-Blockers: Do we know how and in whom they lower blood pressure? Domenic A. Sica OriginalPaper Pages: 296 - 304
Centrally acting antihypertensive drugs: Re-emergence of sympathetic inhibition in the treatment of hypertension Claude R. Benedict OriginalPaper Pages: 305 - 312
Intensive antihypertensive treatment to the new lower blood pressure targets William J. Elliott OriginalPaper Pages: 313 - 319
Chronotherapeutics: Are there meaningful differences among antihypertensive drugs? Luc PoirierJean LefebvreYves Lacourciere OriginalPaper Pages: 320 - 327
Left ventricular hypertrophy: Unresolved issues James A. Schoenberger Clinical Trials Review Pages: 331 - 332
The hypertension optimal treatment study: What did it give us? Robert J. BrygWilliam F. Graettinger OriginalPaper Pages: 337 - 341
Reflections on the sixth report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure Sheldon G. ShepsEdward J. Roccella OriginalPaper Pages: 342 - 345
The world health organization—International society of hypertension blood pressure lowering treatment trialists’ collaboration: Prospective collaborative overviews of major randomized trials of blood pressure-lowering treatments Bruce NealStephen MacMahon OriginalPaper Pages: 346 - 356
Issues of clinical trial design and data interpretations in hypertension Lewis H. Kuller OriginalPaper Pages: 357 - 362
